CCDC78 and the Pathogenesis of Centronuclear Myopathy
CCDC78 and the Pathogenesis of Centronuclear Myopathy
批准号:
8890312
负责人:
JAMES J DOWLING
金额:
$2.73万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2015-06-30
关键词:
3&apos Splice SiteBindingBiochemicalBiopsyCell NucleusCentronuclear myopathyChildhoodChimeric ProteinsChromosome MappingCo-ImmunoprecipitationsComplementary DNACouplingDataDevelopmentDiseaseDominant-Negative MutationEvaluationFamilyFigs - dietaryFutureGene ExpressionGene MutationGenesGeneticGoalsHematoxylin and Eosin Staining MethodImage AnalysisImmunoprecipitationIn VitroKnowledgeLifeMediatingModelingMorbidity - disease rateMotorMuscleMuscle DevelopmentMuscle WeaknessMuscle functionMutateMutationMyopathyPathogenesisPathologicProductionPropertyProteinsProteomicsRoleSarcoplasmic ReticulumSkeletal MuscleStaining methodStainsTechniquesTestingWorkZebrafishcDNA Expressioncombinatorialdisabilityeffective therapyexomeexome sequencinggenetic linkage analysisgenetic pedigreein vivoloss of functionmortalitymuscular structuremutantnext generation sequencingnovelprobandprotein functiontherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Centronuclear myopathies are a group of childhood onset muscle diseases defined by shared muscle biopsy features and characterized by muscle weakness and severe motor disability. Currently there are 5 known genetic causes for CNM, and recent studies on these gene products have identified abnormal excitation- contraction coupling as a key aspect of disease pathogenesis. Despite these advancements, no treatments current exist for CNMs and much remains to be understood about these clinically severe conditions. Approximately 40% of cases of CNM are genetic unresolved. Determination of additional genetic causes is critical to advance the knowledge of and to develop treatments for this disease. We have used linkage analysis and whole exome sequencing to identify a novel gene mutation in the CCDC78 gene in a family with autosomal dominant CNM. CCDC78 encodes a previously uncharacterized gene product, and the gene mutation is predicted to result in production of a protein with an internal deletion. Our hypotheses are that (a) wild type CCDC78 is required for muscle development and in particular for stabilizing the excitation-contraction coupling machinery and that (b) mutant CCDC78 functions in a dominant negative manner to sequester ECC proteins and thereby impair motor function. These hypotheses will be tested in two aims. Aim 1 will examine the function(s) of wild type CCDC78 and Aim 2 will test the impact of the CCDC78 mutation on muscle development and function. Both aims will utilize a combinatorial approach that includes in vitro studies, biochemical and proteomic techniques, and in vivo experimentation in the zebrafish. In particular, the project will take advantage of the
power in the zebrafish for manipulation of gene expression, used to create both loss of function and dominant negative models, and live image analysis, used to dynamically examine specific properties of muscle function. In all, this proposal will determine the function of CCDC78 in muscle development as well as the pathogenic mechanisms underlying its mutation in CNM. These data will be placed in the context of the existing knowledge of CNM, allowing for critical advancements in the understanding of muscle function and the pathogenesis of this devastating disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease
-
批准号:10753786
-
项目类别:
-
资助金额:$19.66万
-
财政年份:2023
-
负责人:JAMES J DOWLING
-
依托单位:
Environmental and Epigenetic Modifiers of Susceptibility to Malignant Hyperthermia and Environmental Heat Stroke
-
批准号:10606166
-
项目类别:
-
资助金额:$79.69万
-
财政年份:2022
-
负责人:JAMES J DOWLING
-
依托单位:
Pathophysiology and Treatment of Recessive RYR1 Related Myopathy
-
批准号:10405495
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2020
-
负责人:JAMES J DOWLING
-
依托单位:
Pathophysiology and Treatment of Recessive RYR1 Related Myopathy
-
批准号:10640863
-
项目类别:
-
资助金额:$40.35万
-
财政年份:2020
-
负责人:JAMES J DOWLING
-
依托单位:
Pathophysiology and Treatment of Recessive RYR1 Related Myopathy
-
批准号:10224943
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2020
-
负责人:JAMES J DOWLING
-
依托单位:
Novel gene based therapy for nemaline myopathy
-
批准号:10216977
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2019
-
负责人:JAMES J DOWLING
-
依托单位:
Novel gene based therapy for nemaline myopathy
-
批准号:10458505
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2019
-
负责人:JAMES J DOWLING
-
依托单位:
Novel gene based therapy for nemaline myopathy
-
批准号:10020762
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2019
-
负责人:JAMES J DOWLING
-
依托单位:
Novel gene based therapy for nemaline myopathy
-
批准号:10665673
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2019
-
负责人:JAMES J DOWLING
-
依托单位:
CCDC78 and the Pathogenesis of Centronuclear Myopathy
-
批准号:8768983
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2012
-
负责人:JAMES J DOWLING
-
依托单位:
CCDC78 and the pathogenesis of centronuclear myopathy
-
批准号:8288935
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2012
-
负责人:JAMES J DOWLING
-
依托单位:
CCDC78 and the Pathogenesis of Centronuclear Myopathy
-
批准号:9032892
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2012
-
负责人:JAMES J DOWLING
-
依托单位:
Myotubularin and the Pathogenesis of Myotubular Myopathy
-
批准号:7586909
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2008
-
负责人:JAMES J DOWLING
-
依托单位:
Myotubularin and the Pathogenesis of Myotubular Myopathy
-
批准号:7751270
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2008
-
负责人:JAMES J DOWLING
-
依托单位:
Myotubularin and the Pathogenesis of Myotubular Myopathy
-
批准号:8197213
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2008
-
负责人:JAMES J DOWLING
-
依托单位:
Myotubularin and the Pathogenesis of Myotubular Myopathy
-
批准号:8394592
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2008
-
负责人:JAMES J DOWLING
-
依托单位:
Myotubularin and the Pathogenesis of Myotubular Myopathy
-
批准号:8009869
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2008
-
负责人:JAMES J DOWLING
-
依托单位:
MURINE NEURODEGENERATIVE DISORDER
-
批准号:2242892
-
项目类别:
-
资助金额:$0.65万
-
财政年份:1996
-
负责人:JAMES J DOWLING
-
依托单位:
海外基金